Le Lézard
Classified in: Health, Science and technology

OpSens to Participate in Virtual Fireside Chat at the 2021 RBC Capital Markets Global Healthcare Conference


Presentation at 11:30 a.m. ET on Wednesday, May 19, 2021

QUEBEC CITY, May 13, 2021 /CNW Telbec/ - OpSens Inc. ("OpSens" or the "Company") (TSX: OPS) (OTCQX: OPSSF),  a medical device cardiology-focused company commercializing a  second-generation fiber optic pressure guidewire to diagnose and treat coronary disease, announced today it will participate in a virtual fireside chat at the 2021 RBC Capital Markets Global Healthcare Conference, which is taking place from May 18-20, 2021. Presentation details are listed below.

Presenter: Louis Laflamme, President & Chief Executive Officer of OpSens Inc.

Date: Wednesday, May 19, 2021

Time: 11:30 AM Eastern Daylight Time

Webcast Link: Please click here

The Company will also be participating in one-on-one investor meetings at the conference. To schedule a meeting, please contact your RBC representative or email [email protected].

A live webcast of the fireside chat will also be available on the Investors page of OpSens' website at www.OpSens.com and will be archived for two weeks.

About OpSens Inc. (www.OpSens.com or www.OpSensmedical.com)

OpSens focuses mainly on coronary physiology products in interventional cardiology. OpSens offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. Its flagship product, the OptoWire, is a second-generation fiber optic pressure guidewire designed to provide the lowest drift in the industry and excellent lesions access. The OptoWire has been used in the diagnosis and treatment of over 100,000 patients in more than 30 countries. It is approved for sale in the United States, European Union, Japan, and Canada.

OpSens is also involved in industrial activities in developing, manufacturing, and installing innovative fiber optic sensing solutions for critical applications.

SOURCE OPSENS Inc.


These press releases may also interest you

at 14:05
YC-Backed Yoneda Labs Raises $4 Million Seed Led by Khosla Ventures to Build Foundation Model for Chemists
Yoneda Labs, the Y Combinator startup building a foundation model for chemists working in drug discovery, today announced it has raised $4 million in seed capital from Khosla Ventures, 500 Emerging Europe, 468 Capital, Fellows Fund, and Y Combinator....

at 14:00
People USA, in partnership with The Office of Mental Health, provides supportive housing for individuals re-entering the community from incarceration
People USA, funded by and in partnership with the New York State Office of Mental Health (OMH), is set to open 20 new scattered site housing units that will support individuals re-entering the community from New...

at 13:45
Harbor Point at Centerville Assisted Living Community Named One of the Country's Best by U.S. News & World Report for Third Straight Year
Harbor Point at Centerville, a Benchmark Mind & Memory Care community, has ranked among the best assisted living with memory care communities in Massachusetts and the entire U.S. for the third straight year. In U.S. News & World Report's third annual...

at 13:45
Crescent Point at Niantic Assisted Living Community Named One of the Country's Best by U.S. News & World Report for Third Straight Year
Crescent Point at Niantic, a Benchmark assisted living and Mind & Memory Care community, has ranked among the best assisted living with memory care communities in Connecticut and the entire U.S. for the third straight year. In U.S. News & World...

at 13:22
Florida's Leading Podiatric Group Takes Giant Leap Into Texas
Houston, we don't have a foot care problem ? now that Modern Foot & Ankle has moved into the Lone Star State. The podiatric group originated in Florida and has a strong presence in Tampa, Orlando, and Palm Beach. But with its recent acquisition of a...

at 13:05
Dr. J. Mark Tuthill Joins Gestalt Diagnostics' Strategic Advisory Board
Gestalt Diagnostics has added healthcare industry expert, Dr. J. Mark Tuthill, to serve on Gestalt's Advisory Board. He will be joining Gestalt's distinguished Advisory Board of pathologists contributing to oversight and active input of development...

More news about Health...


News published on and distributed by: